Not an SEC registrant

Cephalon, Inc.

Customers

None disclosed

Suppliers

0 disclosed

Latest period

Dec 31, 2021

10-K filed 2022-03-08

Suppliers 1

Companies that disclose Cephalon, Inc. as a major customer, as a share of their own revenue. 0 active, 1 lapsed.

Company	% of their revenue	Est. $ from Cephalon, Inc.	Period	Trend	Status	Source
EAGLE PHARMACEUTICALS, INC. EAGLE PHARMACEUTICALS, INC.	66%	$113.2M	FY 2021-12-31	−1.0pp	Lapsed Last seen 2021-12-31	10-K 2022-03-08
Cephalon, Inc. (Teva) - See Revenue Recognition 66 % 67 % 77 % 10-K filed 2022-03-08 Period FY 2021-01-01 to 2021-12-31 (66%), FY 2020-01-01 to 2020-12-31 (67%), FY 2019-01-01 to 2019-12-31 (77%)Accession 0000827871-22-000008 Cephalon, Inc. (Teva) - See Revenue Recognition 66 % 65 % 10-Q filed 2021-05-10 Period 3M 2021-01-01 to 2021-03-31 (66%), 3M 2020-01-01 to 2020-03-31 (65%)Accession 0000827871-21-000016 Cephalon, Inc. (Teva) - See Revenue Recognition 74 % 85 % 72 % 78 % 10-Q filed 2020-11-02 Period 3M 2020-07-01 to 2020-09-30 (74%), 3M 2019-07-01 to 2019-09-30 (85%)Accession 0000827871-20-000028 Cephalon, Inc. (Teva) - See Revenue Recognition 78 % 67 % 71 % 75 % 10-Q filed 2020-08-10 Period 3M 2020-04-01 to 2020-06-30 (78%), 3M 2019-04-01 to 2019-06-30 (67%)Accession 0000827871-20-000024 Cephalon, Inc. (Teva) - See Revenue Recognition 65 % 84 % 10-Q filed 2020-05-11 Period 3M 2019-01-01 to 2019-03-31 (84%)Accession 0000827871-20-000014 Cephalon, Inc. (Teva) - See Revenue Recognition 67 % 77 % 75 % 10-K filed 2021-03-05 Period FY 2018-01-01 to 2018-12-31 (75%)Accession 0000827871-21-000011 Cephalon, Inc. (Teva) - See Revenue Recognition 85 % 74 % 78 % 75 % 10-Q filed 2019-11-12 Period 3M 2018-07-01 to 2018-09-30 (74%)Accession 0000827871-19-000026 Cephalon, Inc. (Teva) - See Revenue Recognition 67 % 70 % 75 % 76 % 10-Q filed 2019-08-08 Period 3M 2018-04-01 to 2018-06-30 (70%)Accession 0000827871-19-000020 Cephalon, Inc. (Teva) - See Revenue Recognition 84 % 84 % 10-Q filed 2019-05-07 Period 3M 2018-01-01 to 2018-03-31 (84%)Accession 0000827871-19-000013 Cephalon, Inc. (Teva) - See Revenue Recognition 77 % 75 % 79 % 10-K filed 2020-03-02 Period FY 2017-01-01 to 2017-12-31 (79%)Accession 0000827871-20-000007 Cephalon, Inc. (Teva) - See Revenue Recognition 74 % 67 % 75 % 78 % 10-Q filed 2018-11-01 Period 3M 2017-07-01 to 2017-09-30 (67%)Accession 0000827871-18-000010 Cephalon, Inc. (Teva) - See Revenue Recognition 70 % 77 % 76 % 83 % 10-Q filed 2018-08-07 Period 3M 2017-04-01 to 2017-06-30 (77%)Accession 0000827871-18-000008 Cephalon, Inc. (Teva) - See Revenue Recognition 84 % 87 % 10-Q filed 2018-05-10 Period 3M 2017-01-01 to 2017-03-31 (87%)Accession 0000827871-18-000005 Cephalon, Inc. (Teva) - See Revenue Recognition 75 % 79 % 79 % 10-K filed 2019-02-28 Period FY 2016-01-01 to 2016-12-31 (79%)Accession 0000827871-19-000008 Cephalon, Inc. (Teva) - See Revenue Recognition 67 % 77 % 78 % 72 % 10-Q filed 2017-11-08 Period 3M 2016-07-01 to 2016-09-30 (77%)Accession 0000827871-17-000010 Cephalon, Inc. (Teva) - See Revenue Recognition 77 % 80 % 83 % 71 % 10-Q filed 2017-08-09 Period 3M 2016-04-01 to 2016-06-30 (80%)Accession 0000827871-17-000007 Cephalon, Inc. (Teva) - See Revenue Recognition 87 % 61 % 10-Q filed 2017-05-08 Period 3M 2016-01-01 to 2016-03-31 (61%)Accession 0000827871-17-000004

Alerts are coming

Get an email when Cephalon, Inc.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.